Found 0 matching trials
A Comparison Study Between 10 Days of Dry Immersion Versus 10 Days of Head-down Bedrest on 20 Healthy Male Volunteers
NAThe space agencies are actively engaged in studying the physiological adapt...
Location
Medes-Institut de Médecine et de Physiologie Spatiale
Transplantation After Complete Response In Patients With T-cell Lymphoma
NAPeripheral T-cell lymphoma (PTCL) encompasses a broad range of post-thymic ...
Location
Chu D'Amiens - Hopital Sud
Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support
PHASE2This study evaluates induction therapy with carfilzomib-cyclophosphamide-de...
Location
Aalborg University Hospital
GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma
PHASE1Objective of study: To evaluate the safety and efficacy of infusional gemci...
Location
Tom Baker Cancer Center
Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT
PHASE2The primary objective of this study is to determine the rate of molecular r...
Location
Tampere University Hospital
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
PHASE2Clinical trial for the safety and efficacy of CD19 CAR-T following autologo...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
PHASE2The purpose of this study is to test any good and bad effects of the study ...
Location
City of Hope Cancer Center (Data Collection Only)
The Effect of Potassium Bicarbonate on Bone and Several Physiological Systems During Immobilisation
NAMainly due to the absence of gravitational forces in weightlessness, astron...
Location
German Aerospace Centre (DLR)
Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma
PHASE2Multiple myeloma (MM) is a common incurable blood cancer causing debilitati...
Location
University of Michigan Comprehensive Cancer Center
FIL Study on ABVD DD-DI as Upfront Therapy in HL.
PHASE3The FIL-Rouge is a randomized, open-label, multicenter, phase III, 2-arm st...
Location
I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1